Fiona Nohilly

Marketing @Illumina | @UCSanDiego Alum

[Illumina @illumina]

We’ve spent years pushing the limits of what short-read sequencing can do. Now, with our emerging constellation mapped read technology, we’re breaking new barriers and enabling the industry to uncover even deeper insights from the genome.

@GeneDx recently piloted constellation to evaluate its performance in the most challenging genomic regions. Early results illustrate its ability to rapidly identify hard-to-detect variants implicated in rare disease, like DMPK, SMN1, and mosaic aneuploidy.

Joe Devaney, Director of the Laboratory Innovation Team at GeneDx, said: “We’re continually looking to advance research and clinical genomics to drive the future of precision medicine and better health outcomes for all. The level of detail we can achieve with Constellation provides promising insight into some of the world’s most complex and difficult-to-diagnose diseases.”

Constellation delivers long-range genomic insights with a simplified, on-flow-cell library prep that removes manual steps — all within the workflows our customers know and trust.

📍GeneDx presented the results of their pilot today at #ASHG25. Read more here: https://t.co/P1B86PUwfb

[Keith Robison @OmicsOmicsBlog]

2x300 on NovaSeq X #agbt25

[Fiona Nohilly @fnohilly]

2x500 (1000cycles) coming to MiSeq i100 - shipping next week!

[Keith Robison @OmicsOmicsBlog]

MiSeq i100 1000 cycle (2x500) kits coming soon #AGBT25

[Illumina @illumina]

These innovations are real—and customers are generating amazing insights with them TODAY. And even more is coming. For a deep dive into multiomics and informatics, don’t miss our #ASHG25 Industry Ed sessions tomorrow at 12pm and 3pm ET: https://t.co/XKuNDe8jmQ (6/6)

[Illumina @illumina]

At #ASHG25, KOL Bekim Sadikovic demonstrated the power of the new Illumina 5-base solution for accelerating resolution of rare disease cases. "Illumina's comprehensive 5-base technique—with the ability to use the combined genome sequencing and epigenetic data simultaneously—has the potential to change the way we look at functional genomics,” he said. (5/6)

[Illumina @illumina]

During his industry education session today at #ASHG25, CTO Steve Barnard shared further updates on how Illumina innovations are transforming insights as we lead the industry into a new era of omics. (1/6)

[Illumina @illumina]

🧬 Register to watch the session on-demand here: https://t.co/XKuNDe8jmQ (7/7) #ASHG25

[Illumina @illumina]

🧬 Early access user GeneDx reported accuracy, speed, and ease of use in their trial of Illumina’s up-and-coming constellation innovation. GeneDx’s Joe Devaney joined Steve on stage at #ASHG25 to discuss how it outperformed orthogonal methods in identifying difficult-to-map variants. (6/7)

[Illumina @illumina]

🧬 A novel way to visualise and resolve even chromosome scale complex structural variants – the colocation plot enables mapping of breakpoints with each variant type, inversion, duplication etc, giving a unique pattern. #ASHG25 (5/7)

[Illumina @illumina]

🧬 Constellation enables phasing of more full-length genes – fully phasing >97% of genes to allow better understanding of heritability and pathogenicity. #ASHG25 (4/7)

[Illumina @illumina]

🧬 Constellation delivers our most comprehensive and accurate genome yet—up to 90% fewer small variant errors than other platforms. Spend less time chasing false positives and negatives, and more time on real insights. #genomics #ASHG25 (3/7)

[Illumina @illumina]

🧬 Previously, researchers had to choose between simplicity, scalability, and long-distance genomic insights. With constellation, you get simplicity (zero library prep), reliability of Illumina sequencing, accuracy in the most difficult parts of the genome, complex SVs, haplotype resolved paralogs, Mb scale phasing, and more. #ASHG25 (2/7)

[Illumina @illumina]

🧬 Today at #ASHG25, CTO Steve Barnard shared how constellation is transforming whole-genome sequencing—delivering accurate phasing, resolving structural variants, accessing difficult regions with unprecedented simplicity. (1/7)

[Fiona Nohilly @fnohilly]

heading to Boston next week for ASHG! who's gonna be there?

[David Silva @DaveS_i_l_v_a]

🚨 New tech blog post from @illumina on constellation🌌 mapped read technology for long-range genomic insights for human #WGS from #NovaSeq X systems. https://t.co/3vQgUJhLqL

[Illumina Live Events @illuminaLive]

Packed house at our Industry Education Session happening now at #ASHG24. Preview our latest advancements in #NGS and multiomics, including our groundbreaking constellation mapped read technology! Be sure to stop by booth 503 to learn more if you can't make it. 🧬

[Fiona Nohilly @fnohilly]

MiSeq i100 in the wild!!! check it out our booth at #ASHG24 🧬

[Illumina Live Events @illuminaLive]

New MiSeq i100 Series on Display 🚀Stop by booth 503 at #ASHG24 to see our new MiSeq i100 Series firsthand. Join us to discover the power of these innovative sequencing systems and explore our recent scientific findings in five presentations and abstracts.
#genomics #illumina

[Illumina Live Events @illuminaLive]

#ASHG24 attendees, get ready to see Illumina’s most comprehensive genome yet! Join us and @BroadGenomics tomorrow at 12 pm as Dr. Steve Barnard introduces constellation mapped read technology and the future of whole-genome sequencing🌌. See you there! #Genomics

[Fiona Nohilly @fnohilly]

@AntoBeck @BioMath @illumina @agtaGenomics @agbt those designs looks familiar @AntoBeck ;)
@BioMath we will have some goodies at ASHG & AGBT 25, be sure to stop by our events for all the #MiSeqi100 swag!

[Fiona Nohilly @fnohilly]

very interesting and frightening. thankfully we've stopped doing treatments with cadaver derived growth hormones https://t.co/npv7yW6QJp #Alzheimersresearch